We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

26 Oct 2026 - 29 Oct 2026
16 Nov 2026 - 19 Nov 2026

Sprayable Powder-Type Hemostatic Agent Stops Bleeding in One Second

By HospiMedica International staff writers
Posted on 12 Jan 2026

Uncontrolled bleeding remains the leading cause of preventable death from injuries. More...

Rapid blood loss can be fatal within minutes, especially when wounds are deep, irregular, or difficult to compress. Existing hemostatic patches are often ineffective in such scenarios and can be impractical in harsh environments. New research now presents a spray-on powder that can stop bleeding within one second, offering a potential breakthrough for emergency care, especially in medically underserved areas.

An interdisciplinary team of researchers at the Korea Advanced Institute of Science and Technology (Daejeon, South Korea) has designed a powder-type hemostatic agent optimized for emergency medicine. The agent rapidly transforms into a strong hydrogel barrier upon contact with blood, enabling immediate wound sealing without complex preparation.

The researchers focused on overcoming the limitations of flat, patch-based hemostatic products by creating a free-flowing powder suitable for deep and irregular wounds. The formulation, known as AGCL powder, combines naturally derived materials including alginate and gellan gum, which undergo ultra-fast gelation in the presence of calcium ions, and chitosan, which enhances biological clotting through interaction with blood components. The powder’s internal three-dimensional structure was engineered to maximize blood absorption and adhesion.

The AGCL powder gelled within approximately one second after application and absorbed more than seven times its own weight in blood. It demonstrated strong sealing performance under high-pressure bleeding, with adhesive strength exceeding 40 kPa, outperforming commercial hemostatic agents. Safety testing showed low hemolysis, high cell viability, and strong antibacterial activity. In animal models, the powder reduced bleeding time, promoted tissue regeneration, and supported normal organ recovery without systemic toxicity.

The hemostatic agent maintained performance for up to two years under room temperature and high-humidity conditions, making it suitable for storage and rapid deployment in resource-limited settings. The technology could be used widely in emergency medicine, trauma care, and humanitarian response, where rapid bleeding control is critical.

Related Links:
KAIST


Gold Member
12-Channel ECG
CM1200B
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Tourniquet System
heidi– mein Tourniquet
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Half-matched bone marrow transplant expands access to curative treatment for children and young adults with severe aplastic anemia. (Photo courtes of Margarita Dionysiou using Bio Render)

Half-Matched Family Donors Could Expand Transplant Access for Severe Aplastic Anemia

Severe aplastic anemia is a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells, leaving children and young adults vulnerable to anemia, infection, and bleeding.... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.